Eli Lilly invites you to a medical education meeting on the diagnosis and management of RET-driven cancers, featuring medical oncologists Dr. TP Sahoo and Dr. Nikhil Ghadyalpatil. The experts will discuss : The importance of precision oncology and cancer genomics in advancing targeted therapies RET as a therapeutic target in non-small cell lung cancer and medullary thyroid cancer Current treatment approaches through case-based discussion Real-world challenges in the management of RET-driven cancers in the Indian context Join us on September 1 at 7:30 PM IST for this expert-led session exploring the journey from testing to treatment in RET-driven cancers.

We look forward to your participation. Agenda : This content is approved by Eli Lilly and Company (“Lilly”). This content is the intellectual property of Lilly and its reproduction needs Lilly's prior permission. Website:…